2040 is a better bet and it shouldn't be low. Enough time to mature biotech for novel biologics outside of nature and the technological means(method + access) to pose risk. Ugh pinker is such a pseud in the ivory tower.
To would be downvoters, list contributions of pinker that's novel and long lasting? Until then I'll continue to view him as another overrated commercial intellectual.